Science Explorer Back to mapMap
Discussion
Researcher · Icahn School of Medicine at Mount Sinai · United States

Mark Lebwohl

Mark Lebwohl publishes mostly in Immunology, Dermatology and Rheumatology, on topics such as Psoriasis: Treatment and Pathogenesis, Dermatology and Skin Diseases and Spondyloarthritis Studies and Treatments.

ORCID 0000-0002-4705-5303 OpenAlex
World rank
#244,776
of 7,710,434 ranked researchers
Rank in United States
#90,035
of 1,627,098
Works
1,410
Citations
57k
Citations per work
40.7
h-index
121
i10-index 556Top 0.2% in Immunology
Mark Lebwohl

What does Mark Lebwohl research?

Mark Lebwohl's work is mostly in Medicine (38%), Immunology and Microbiology (25%), Biochemistry, Genetics and Molecular Biology (4%).

Health Sciences: 533 works · 37.8% of their workMedicine: 533 works · 37.8% of their workDermatology: 237 works · 16.8% of their workRheumatology: 159 works · 11.3% of their workEpidemiology: 78 works · 5.5% of their workPathology and Forensic Medicine: 59 works · 4.2% of their workEverything else: 475 works · 33.7% of their workLife Sciences: 402 works · 28.5% of their workImmunology and Microbiology: 351 works · 24.9% of their workImmunology: 351 works · 24.9% of their workBiochemistry, Genetics and Molecular Biology: 51 works · 3.6% of their workMolecular Biology: 51 works · 3.6% of their workTHEIR WORKMark Lebwohl1,410works
Life Sciences28%Health Sciences38%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine53337.8%
  2. Everything else47533.7%
    1. Immunology and Microbiology35124.9%
    2. Biochemistry, Genetics and Molecular Biology513.6%
  1. 1Immunology25% of their works
  2. 2Dermatology17% of their works
  3. 3Rheumatology11% of their works
  4. 4Epidemiology6% of their works
  5. 5Pathology and Forensic Medicine4% of their works
  6. 6Molecular Biology4% of their works

Research topics

Which keywords describe Mark Lebwohl's research?

The keywords of their largest research topics: IL-17, TH17 Cells, Filaggrin, Skin Microbiome, Ankylosing Spondylitis, Spondyloarthritis, Autoantibodies and Pemphigoid.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 17 words, with their numbers
  1. IL-178351 topic
  2. TH17 Cells8351 topic
  3. Filaggrin3921 topic
  4. Skin Microbiome3921 topic
  5. Ankylosing Spondylitis2481 topic
  6. Spondyloarthritis2481 topic
  7. Autoantibodies2172 topics
  8. Pemphigoid1371 topic
  9. Rituximab1371 topic
  10. Off-Label Drug Use1141 topic
  11. Pediatric Pharmacokinetics1141 topic
  12. Cost-effectiveness Analysis1071 topic
  13. Quality of Life1071 topic
  14. Inflammation801 topic
  15. Rheumatoid Arthritis801 topic
  16. Nonmelanoma Skin Cancer761 topic
  17. Skin Cancers761 topic

Where does Mark Lebwohl work?

Mark Lebwohl's main affiliation in the publication record is Icahn School of Medicine at Mount Sinai, United States.

How many publications and citations does Mark Lebwohl have?

OpenAlex counts 1,410 works and 57,442 citations for Mark Lebwohl, an h-index of 121, ranking #244,776 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Mark Lebwohl. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.